Hybrid Cyclic Libraries With V5 Readout for Proteome Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge is to develop new compounds and methods for screening chemical libraries against the human proteome using protein chips due to the lack of a universal readout for detecting ligand-protein binding, which is hindered by interference from artificial tags in existing chemical libraries.
Innovation Solution
The development of hybrid cyclic molecules, specifically compounds of Formula I, which include an Effector Domain and a Resin, for use in screening against human protein chips, utilizing the anti-V5 antibody and fluorescently tagged secondary antibodies to detect binding and determine protein function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If chemical libraries are screened against human protein chips, then protein interactions can be identified and protein functions can be determined, but artificial tags in existing chemical libraries interfere with detection
Solution Approach 1:
The patent removes artificial tags from chemical libraries that interfere with detection, and replaces them with natural amino acid tags (such as V5 tag) that do not interfere with the detection system. This extraction of harmful elements and replacement with beneficial alternatives resolves the contradiction between maintaining library functionality and eliminating detection interference.
Solution Approach 2:
The patent introduces an intermediary detection system using anti-V5 antibodies and fluorescently tagged secondary antibodies that specifically recognize the V5 tag on bound compounds without interfering with the ligand-protein binding itself. This intermediary detection mechanism allows accurate measurement while avoiding direct interference from library components.
2Productivity
If a universal readout method is developed for detecting ligand-protein binding, then screening effectiveness is improved, but the complexity of the detection system increases
Solution Approach 1:
The patent develops a universal readout method based on the V5 tag that can be applied across different protein chips and screening conditions. The anti-V5 antibody detection system serves multiple functions: it detects bound compounds, provides quantitative information, and works with various protein targets. This universal approach increases screening effectiveness while managing complexity through standardization.
Solution Approach 2:
The patent employs fluorescently tagged secondary antibodies that produce detectable color/fluorescence changes upon binding to the V5 tag. This optical signal change provides a simple, visual readout that translates complex binding events into easily measurable signals, improving productivity without proportionally increasing system complexity.
3Reliability
If hybrid cyclic molecules with V5 tag are used in chemical libraries, then detection reliability is improved, but the ease of manufacture of chemical libraries is reduced
Solution Approach 1:
The patent segments the chemical library compounds into modular components, with the V5 tag as a separate, standardized element that can be independently synthesized and then coupled to diverse ligand structures. This segmentation allows the detection-reliable V5 tag to be systematically integrated into many different compounds without redesigning the entire library synthesis pathway each time.
Solution Approach 2:
The patent performs preliminary synthesis of the V5 tag component and prepares it for coupling before final library assembly. By pre-synthesizing the detection-tagged component and having it ready for efficient coupling to various ligands, the overall manufacturing process becomes more streamlined despite the added complexity of the tagged structure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables effective screening of chemical libraries against the human proteome by providing a reliable method to identify protein interactions and determine protein function, facilitating the elucidation of protein functions and potential therapeutic applications.
Implementation Method 1
utilizing the anti-V5 antibody and fluorescently tagged secondary antibodies to detect binding
Data Source
AI summary
Provided are novel types of hybrid cyclic libraries that contain a known protein binding domain of a natural product. Also provided are synthetic methods to make such libraries and methods for the deconvolution of hits using partially split-pooled library compounds. Such methods are applicable for use with the entire human proteome to screen such libraries that bind and for the identification of hits.